Phobia Clinical Trial - Cortisol in the Treatment of Phobias

Status Completed

Clinical Trial Summary

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00451750
Study type	Interventional
Source	University of Zurich
Contact
Status	Completed
Phase	N/A
Start date	May 2007
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04977544` - Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder	N/A
Completed	`NCT03655262` - Treating Phobia With Multivoxel Neuro-reinforcement	N/A
Completed	`NCT03658252` - Efficacy of Targeted Intervention for Topical Steroid Phobia.	N/A
Completed	`NCT04782570` - Psychotherapy of Anxiety Disorders With Noninvasive Brain Stimulation - Using Virtual Reality	N/A
Recruiting	`NCT03528109` - Improving Access to Child Anxiety Treatment	N/A
Not yet recruiting	`NCT03813823` - Biobehavioral Correlates of Acute Phobic Fear
Completed	`NCT02810171` - Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety	N/A
Completed	`NCT02223767` - TMS Augmented Exposure Therapy	N/A
Terminated	`NCT04019054` - TMS and Exposure Therapy	N/A
Recruiting	`NCT03498599` - Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety	N/A